Pharma Foods International Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802310007
JPY
686.00
-55 (-7.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Apr'25
Jan'25
Oct'24
Jul'24
Apr'24
Jan'24
Oct'23
Net Sales
16,960.00
15,261.00
14,596.00
14,976.00
15,519.00
15,510.00
16,142.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,960.00
15,261.00
14,596.00
14,976.00
15,519.00
15,510.00
16,142.00
Raw Material Cost
3,528.00
2,892.00
2,713.00
3,544.00
3,336.00
3,167.00
3,447.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
27.00
17.00
24.00
18.00
17.00
13.00
14.00
Selling and Distribution Expenses
13,951.00
12,327.00
10,663.00
9,312.00
10,229.00
11,204.00
11,816.00
Other Expenses
29.50
28.40
31.30
25.50
20.60
19.20
26.30
Total Expenditure (Excl Depreciation)
17,801.00
15,520.00
13,713.00
13,129.00
13,788.00
14,576.00
15,540.00
Operating Profit (PBDIT) excl Other Income
-841
-259
883
1847
1731
934
602
Other Income
-10.00
32.00
29.00
95.00
-23.00
18.00
16.00
Operating Profit (PBDIT)
-650.00
-37.00
1,091.00
2,375.00
1,865.00
1,125.00
762.00
Interest
27.00
17.00
24.00
18.00
17.00
13.00
14.00
Exceptional Items
0.00
0.00
0.00
-123.00
0.00
0.00
0.00
Gross Profit (PBDT)
13,432.00
12,369.00
11,883.00
11,432.00
12,183.00
12,343.00
12,695.00
Depreciation
201.00
190.00
179.00
433.00
157.00
173.00
144.00
Profit Before Tax
-876.00
-243.00
888.00
1,800.00
1,692.00
937.00
605.00
Tax
477.00
-112.00
527.00
451.00
603.00
456.00
318.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1,352.00
-131.00
360.00
1,349.00
1,088.00
482.00
286.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1,352.00
-131.00
360.00
1,349.00
1,088.00
482.00
286.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1,352.00
-131.00
360.00
1,349.00
1,088.00
482.00
286.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
10,239.00
12,048.00
11,479.00
11,585.00
10,015.00
9,202.00
9,687.00
Earnings per share (EPS)
-46.53
-4.51
12.82
48.05
38.76
16.75
9.92
Diluted Earnings per share
-46.53
-4.51
12.82
48.05
38.76
16.75
9.92
Operating Profit Margin (Excl OI)
-4.96%
-1.7%
6.05%
12.33%
11.15%
6.02%
3.73%
Gross Profit Margin
-3.98%
-0.35%
7.31%
14.91%
11.91%
7.16%
4.64%
PAT Margin
-7.97%
-0.86%
2.47%
9.01%
7.01%
3.11%
1.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Apr 2025 is 11.13% vs 4.56% in Jan 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Apr 2025 is -932.06% vs -136.39% in Jan 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Apr 2025 is -827.54% vs -106.50% in Jan 2025

stock-summary

Interest

QoQ Growth in quarter ended Apr 2025 is 58.82% vs -29.17% in Jan 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Apr 2025 has fallen from Jan 2025

Compare Quarterly Results Of Pharma Foods International Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
16,960.00
12,618.00
4,342.00
34.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,960.00
12,618.00
4,342.00
34.41%
Raw Material Cost
3,528.00
3,805.00
-277.00
-7.28%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
27.00
119.00
-92.00
-77.31%
Selling and Distribution Expenses
13,951.00
7,691.00
6,260.00
81.39%
Other Expenses
29.50
-1.50
31.00
2,066.67%
Total Expenditure (Excl Depreciation)
17,801.00
11,600.00
6,201.00
53.46%
Operating Profit (PBDIT) excl Other Income
-841.00
1,018.00
-1,859.00
-182.61%
Other Income
-10.00
-162.00
152.00
93.83%
Operating Profit (PBDIT)
-650.00
1,685.00
-2,335.00
-138.58%
Interest
27.00
119.00
-92.00
-77.31%
Exceptional Items
0.00
-3.00
3.00
100.00%
Gross Profit (PBDT)
13,432.00
8,813.00
4,619.00
52.41%
Depreciation
201.00
829.00
-628.00
-75.75%
Profit Before Tax
-876.00
734.00
-1,610.00
-219.35%
Tax
477.00
446.00
31.00
6.95%
Provisions and contingencies
0
0
0.00
Profit After Tax
-1,352.00
-53.00
-1,299.00
-2,450.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1,352.00
-53.00
-1,299.00
-2,450.94%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
340.00
-340.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1,352.00
287.00
-1,639.00
-571.08%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
10,239.00
30,591.00
-20,352.00
-66.53%
Earnings per share (EPS)
-46.53
-0.38
-46.15
-12,144.74%
Diluted Earnings per share
-46.53
-0.38
-46.15
-12,144.74%
Operating Profit Margin (Excl OI)
-4.96%
8.07%
0.00
-13.03%
Gross Profit Margin
-3.98%
12.39%
0.00
-16.37%
PAT Margin
-7.97%
-0.42%
0.00
-7.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,696.00 Million
in Apr 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2025 is 11.13% vs 4.56% in Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 is 9.29% vs -10.76% in Apr 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -135.20 Million
in Apr 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2025 is -932.06% vs -136.39% in Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 is -224.26% vs -45.11% in Apr 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -64.00 Million
in Apr 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2025 is -827.54% vs -106.50% in Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 is -133.90% vs -28.89% in Apr 2024

Quarterly - Interest
Interest 2.70 Million
in Apr 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2025 is 58.82% vs -29.17% in Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 is 58.82% vs 21.43% in Apr 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -4.96%
in Apr 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Apr 2025 has fallen from Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 has fallen from Apr 2024